Three Months Ended March 31,

Six Months Ended March 31,

(In thousands)

2023

2022

2023

2022

Revenue:

Medical Device

$

19,707

$

18,453

$

38,725

$

35,361

In Vitro Diagnostics

7,491

7,653

13,406

13,748

Total revenue

$

27,198

$

26,106

$

52,131

$

49,109

Operating (loss) income:

Medical Device

$

(7,059

)

$

(5,612

)

$

(14,294

)

$

(9,404

)

In Vitro Diagnostics

3,636

3,720

6,584

6,875

Total segment operating (loss) income

(3,423

)

(1,892

)

(7,710

)

(2,529

)

Corporate

(3,160

)

(3,008

)

(6,102

)

(5,812

)

Total operating (loss) income

$

(6,583

)

$

(4,900

)

$

(13,812

)

$

(8,341

)

Depreciation and amortization:

Medical Device

$

1,933

$

2,133

$

3,886

$

4,327

In Vitro Diagnostics

75

86

152

172

Corporate

84

101

176

197

Total depreciation and amortization

$

2,092

$

2,320

$

4,214

$

4,696